View in EDS

67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC).

Saved in:
Bibliographic Details
Title: 67P High levels of circulating ceramides are associated with poor prognosis in patients with metastatic castration-resistant prostate cancer (mCRPC).
Authors: Cattrini, C.1 (AUTHOR), Manfredi, M.2 (AUTHOR), Barboro, P.3 (AUTHOR), Ghirimoldi, M.2 (AUTHOR), Mennitto, A.2 (AUTHOR), Martini, V.2 (AUTHOR), Battioni, A.2 (AUTHOR), Le Van, M.2 (AUTHOR), Biello, F.2 (AUTHOR), Platini, F.4 (AUTHOR), Ruffilli, B.2 (AUTHOR), Branni, C.4 (AUTHOR), Tassone, A.2 (AUTHOR), Gobbato, S.2 (AUTHOR), Stella, A.2 (AUTHOR), Catalano, F.3 (AUTHOR), Zanardi, E.3 (AUTHOR), Pinato, D.J.5 (AUTHOR), Boccardo, F.6 (AUTHOR), Gennari, A.2 (AUTHOR)
Source: Annals of Oncology. 2022 Supplement 8, Vol. 33, pS1403-S1404. 2p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first